CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $997,452 | -10.8% | 717,591 | -5.6% | 0.00% | – |
| Q2 2023 | $1,117,600 | -10.6% | 760,272 | +0.3% | 0.00% | – |
| Q1 2023 | $1,250,400 | +19.1% | 757,818 | +1.1% | 0.00% | – |
| Q4 2022 | $1,049,784 | -9.0% | 749,846 | +0.1% | 0.00% | – |
| Q3 2022 | $1,153,000 | -22.0% | 749,098 | +11.5% | 0.00% | – |
| Q2 2022 | $1,478,000 | -76.1% | 671,967 | -73.1% | 0.00% | – |
| Q1 2022 | $6,190,000 | -59.3% | 2,496,120 | -1.4% | 0.00% | – |
| Q4 2021 | $15,218,000 | -4.3% | 2,532,248 | +6.1% | 0.00% | – |
| Q3 2021 | $15,903,000 | +1.3% | 2,387,748 | +1.2% | 0.00% | – |
| Q2 2021 | $15,694,000 | +215.8% | 2,359,983 | +339.7% | 0.00% | – |
| Q1 2021 | $4,970,000 | -39.6% | 536,758 | +17.4% | 0.00% | – |
| Q4 2020 | $8,224,000 | +66.8% | 457,201 | +31.6% | 0.00% | – |
| Q3 2020 | $4,931,000 | +17510.7% | 347,474 | +6163.0% | 0.00% | – |
| Q2 2020 | $28,000 | – | 5,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |